On Googles scale from 1 to 100, BPC-157 ranked an 8 in January 2023 and a 100, which denotes its peak popularity, in April of this year
Being ready to answer them may make time to go over points you want to spend more time on
The Proposed BPC 157 Cytoprotective Principle as the Counteraction of the Occlusion/Occlusion-like Syndromes Recently, regarding the particular point of resolving the application in eye pharmacotherapy, the pleiotropic beneficial effect as a particular cytoprotective agents ability was combined with the cytoprotective ability of the pentadecapeptide BPC 157 to further maintain and upgrade endothelium integrity and functioning (for review see [1,2,3,4,5,6,7,8,9,10])
Emmie N M Ho, et al
While some individuals experience rapid benefits, others may require a longer duration of use to see optimal results